Table 1.
Disease site |
Study, source |
Inclusion criteria |
Glioblastoma | CLEOPATRA study; Combs et al, 2010 [17] | • Unifocal, supratentorial glioblastoma, • Treatment with temozolomide, • Previous photon irradiation, • Age older than 18 y |
Hepatocellular carcinoma | PROMETHEUS-01 study; Combs et al, 2011 [18] | • Hepatocellular carcinoma, • No extrahepatic spread, • Age older than 18 y |
Cholangiocarcinoma | J-CROS study; Kasuya et al, 2019 [19] | • Intrahepatic or perihilar cholangiocarcinoma, • Treated with chemotherapy, • No surgery allowed |
Locally advanced pancreatic cancer | PHOENIX [9], CIPHER/NCT03536182 study; UTSWMC, 2018 | • Locally advanced or unresectable pancreatic cancer, • No evidence of distant metastases, • No previous radiation, • Age older than 18 y |
Non–small cell lung cancer | Miyamoto et al, 2003 [20], Miyamoto et al, 2007 [21], Yamamoto et al, 2017 [22], Hayashi et al, 2019 [23] | • Stage I non-small cell lung cancer, • Locally advanced non-small cell lung cancer, • Squamous cell, adenocarcinoma, or large cell of the lung, • Inoperable or refusing surgery |
Localized prostate cancer | Nomiya et al, 2016 [24], Zhang et al, 2019 [25], Kasuya et al, 2017 [26] | • Prostate adenocarcinoma, • T1-3N0, • M0 disease |
Soft tissue sarcoma | Sugahara et al, 2012 [27], Kamada et al. 2002 [28] | • Localized sarcomas, • Extremity, pelvis, or spine location, • No history of previous radiation, • Inoperable |
Salivary gland | COSMIC (NCT01154270) Jensen et al, 2010 [29] | • Inoperable tumor, • Grade 2/3, • R1 or R2 resection, • T3 or T4, • Perineural invasion |
Sinonasal cancers | Koto et al, 2014 [30] | • Definitive carbon ion therapy, • Medically inoperable, • Age 15-79, • No previous radiation |
Nasopharyngeal cancers | Akbaba et al. 2019 [31, 32] | • Locally advanced nasopharyngeal tumors, • Paranasal sinus tumors were excluded |
Abbreviation: UTSWMC, University of Texas Southwest Medical Center.